ST MARY CRAY PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: G84013 | ORPINGTON, BR5 4AR
Showing results 151-200 of 381
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Estriol | 59 | 1,290 | £446 | -72.3% ▼ |
| Cyanocobalamin | 59 | 3,226 | £355 | -83.3% ▼ |
| Dexamethasone | 58 | 5,251 | £2.8K | -2.9% ▼ |
| Estradiol with progestogen | 57 | 1,240 | £1.9K | -83.3% ▼ |
| Hyoscine butylbromide | 56 | 6,468 | £444 | -76.0% ▼ |
| Clobetasone butyrate | 56 | 2,850 | £307 | -72.6% ▼ |
| Tranexamic acid | 55 | 3,248 | £239 | -35.1% ▼ |
| 54 | 54 | £311 | +5.3% ▲ | |
| Topiramate | 53 | 3,896 | £208 | -70.2% ▼ |
| Dapagliflozin/metformin | 53 | 5,936 | £3.7K | +20.7% ▲ |
| Other multivitamin preparations | 53 | 3,062 | £1.1K | -69.3% ▼ |
| 53 | 11.1K | £818 | -47.8% ▼ | |
| 52 | 7,370 | £752 | +7.9% ▲ | |
| Mebeverine hydrochloride | 51 | 4,896 | £222 | -83.6% ▼ |
| Metoclopramide hydrochloride | 51 | 2,597 | £80 | -38.4% ▼ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 51 | 1,805 | £149 | -66.6% ▼ |
| Biphasic isophane insulin | 51 | 345 | £1.5K | -54.3% ▼ |
| Biphasic insulin aspart | 51 | 545 | £3.2K | -49.8% ▼ |
| Dexamethasone | 51 | 260 | £162 | -70.3% ▼ |
| Ranolazine | 50 | 5,444 | £1.0K | -70.6% ▼ |
| Brivaracetam | 50 | 1,820 | £4.2K | +47.0% ▲ |
| Timolol and bimatoprost | 50 | 660 | £932 | -67.1% ▼ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 49 | 77 | £3.4K | -70.7% ▼ |
| Insulin detemir | 49 | 375 | £3.2K | -37.4% ▼ |
| Sulfasalazine | 48 | 11.0K | £1.8K | -63.1% ▼ |
| Tapentadol | 48 | 2,226 | £1.9K | +16.6% ▲ |
| Aciclovir | 48 | 1,763 | £78 | -67.7% ▼ |
| Empagliflozin/metformin | 48 | 4,648 | £2.9K | -7.8% ▼ |
| Medroxyprogesterone acetate | 48 | 48 | £269 | -60.2% ▼ |
| Nicorandil | 47 | 3,960 | £625 | -67.4% ▼ |
| Quinine sulfate | 47 | 1,708 | £304 | -83.8% ▼ |
| Procyclidine hydrochloride | 46 | 2,548 | £97 | -67.5% ▼ |
| Mometasone furoate | 46 | 2,990 | £281 | -65.6% ▼ |
| Bimatoprost | 45 | 1,764 | £662 | -69.7% ▼ |
| Hypromellose | 45 | 560 | £135 | -66.0% ▼ |
| Hydralazine hydrochloride | 44 | 5,320 | £308 | +4.3% ▲ |
| Hydroxychloroquine sulfate | 43 | 3,086 | £134 | -77.8% ▼ |
| Umeclidinium bromide | 42 | 54 | £1.4K | -31.9% ▼ |
| Dihydrocodeine tartrate | 41 | 1,448 | £94 | -79.0% ▼ |
| Colchicine | 41 | 1,891 | £37 | -47.4% ▼ |
| Dorzolamide | 41 | 2,990 | £1.2K | -50.7% ▼ |
| Beclometasone dipropionate | 41 | 44 | £138 | -80.9% ▼ |
| Clobetasol propionate | 41 | 3,180 | £258 | -69.9% ▼ |
| Sacubitril/valsartan | 40 | 3,920 | £6.4K | -83.3% ▼ |
| Solifenacin | 40 | 1,934 | £71 | -91.6% ▼ |
| Febuxostat | 40 | 1,344 | £104 | +7.1% ▲ |
| Brinzolamide/brimonidine | 40 | 215 | £378 | +16.6% ▲ |
| Fluticasone propionate (Nasal) | 40 | 111 | £564 | -72.5% ▼ |
| 40 | 19.3K | £314 | -84.8% ▼ | |
| Ursodeoxycholic acid | 39 | 5,140 | £1.6K | -41.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.